Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

EXPERIMENTAL CONDITION - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:antineoplastic agent
go back to main search page
Accession:XCO:0000435 term browser browse the term
Definition:This is any condition in which the main influencing factor is any chemical that inhibits or prevents the proliferation of neoplasms.
Synonyms:related_synonym: anticancer agent;   cancer chemotherapy agent
 xref: CHEBI:35610


show annotations for term's descendants           Sort by:
Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 0
    therapeutic agent 0
      antineoplastic agent 0
        5-aza-2′-deoxycytidine 0
        5-bromo-2'-deoxyuridine 0
        5-fluorouracil 0
        Allyl isothiocyanate 0
        BTB14431 0
        UNC0638 0
        afatinib 0
        bardoxolone 0
        bleomycin 0
        cisplatin + 0
        clodronic acid + 0
        curcumin 0
        cyclophosphamide 0
        diallyl trisulfide 0
        diethylstilbestrol 0
        doxorubicin + 0
        emodin 0
        enrofloxacin + 0
        epigallocatechin-3-gallate 0
        everolimus 0
        floxuridine + 0
        flutamide 0
        gefitinib 0
        gingerol 0
        lapatinib 0
        letrozole 0
        luteolin 0
        megestrol 0
        nintedanib 0
        oxaliplatin 0
        paclitaxel 0
        perhexiline maleate 0
        phloretin 0
        phosphoramidon 0
        puromycin 0
        sanguinarine 0
        sorafenib 0
        spiroplatin 0
        sunitinib 0
        taurolidine 0
        troglitazone 0
        urethane 0
        vinblastine 0
Path 2
Term Annotations click to browse term
  experimental condition 0
    chemical 0
      chemical with specified function 0
        antineoplastic agent 0
          5-aza-2′-deoxycytidine 0
          5-bromo-2'-deoxyuridine 0
          5-fluorouracil 0
          Allyl isothiocyanate 0
          BTB14431 0
          UNC0638 0
          afatinib 0
          bardoxolone 0
          bleomycin 0
          cisplatin + 0
          clodronic acid + 0
          curcumin 0
          cyclophosphamide 0
          diallyl trisulfide 0
          diethylstilbestrol 0
          doxorubicin + 0
          emodin 0
          enrofloxacin + 0
          epigallocatechin-3-gallate 0
          everolimus 0
          floxuridine + 0
          flutamide 0
          gefitinib 0
          gingerol 0
          lapatinib 0
          letrozole 0
          luteolin 0
          megestrol 0
          nintedanib 0
          oxaliplatin 0
          paclitaxel 0
          perhexiline maleate 0
          phloretin 0
          phosphoramidon 0
          puromycin 0
          sanguinarine 0
          sorafenib 0
          spiroplatin 0
          sunitinib 0
          taurolidine 0
          troglitazone 0
          urethane 0
          vinblastine 0
paths to the root